SynthesisFrontiers in neuroinformatics2019
Novel Technological Solutions for Assessment, Treatment, and Assistance in Mild Cognitive Impairment.
Synthesis in Frontiers in neuroinformatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.
- Functional autonomy in dementia of the Alzheimer's type, mild cognitive impairment, and healthy aging: a meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021Pooled it
- Mobile Health Interventions to Support Patients With Dementia During the COVID-19 Pandemic: A Systematic Review.Health science reports · 2026Review
- Personalized robotic interventions for apathy in dementia: the RAPHAel trial.Frontiers in robotics and AI · 2026Article
- A Novel Working Memory Task-Induced EEG Response (WM-TIER) Feature Extraction Framework for Detecting Alzheimer's Disease and Mild Cognitive Impairment.Biosensors · 2025Article
- Technology for activity participation in older people with mild cognitive impairment or dementia: expert perspectives and a scoping review.Disability and rehabilitation. Assistive technology · 2023Article
- Introducing CARESSER: A framework for in situ learning robot social assistance from expert knowledge and demonstrations.User modeling and user-adapted interaction · 2023Article
- Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.Free neuropathology · 2022Article
- Can assistive technology support social services during Covid-19 emergency? Barriers and opportunities.International journal on interactive design and manufacturing · 2022Article
- Personalizing Care Through Robotic Assistance and Clinical Supervision.Frontiers in robotics and AI · 2022Article
- Biosensors toward behavior detection in diagnosis of alzheimer's disease.Frontiers in bioengineering and biotechnology · 2022Review
- Smart Textiles for Improved Quality of Life and Cognitive Assessment.Sensors (Basel, Switzerland) · 2021Article
- Artificial Vision Algorithms for Socially Assistive Robot Applications: A Review of the Literature.Sensors (Basel, Switzerland) · 2021Review
- Improving wellbeing of community-dwelling people with mild cognitive impairment: the SENIOR (SystEm of Nudge theory based ICT applications for OldeR citizens) project.Neural regeneration research · 2021Review
- Interdisciplinary Research in Alzheimer's Disease and the Roles International Societies Can Play.Aging and disease · 2021Article
- The Collaborative Aging Research Using Technology Initiative: An Open, Sharable, Technology-Agnostic Platform for the Research Community.Digital biomarkers · 2020Article
- Less Is More-Cyclists-Triathlete's 30 min Cycling Time-Trial Performance Is Impaired With Multiple Feedback Compared to a Single Feedback.Frontiers in psychology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease, and dementia, represent a common cause of disability and one of the most relevant challenges in the health world. In addition, these conditions do not have, at moment, a pharmacological treatment that can stop the pathological progress. Mild cognitive impairment (MCI), defined as the borderline between normal aging and early dementia, represents a meaningful field of study because, in the transition to dementia, clinicians have defined a useful therapeutic window. Additionally, due to the lack of effective pharmacological interventions, recent years have seen an increase in research into new technological solutions to assess, stimulate, and assist patients afflicted with Alzheimer's disease. This review aims to outline the use of information and communication technologies in the field studying MCI. Particularly, the goal is to depict the framework and describe the most worthwhile research efforts, in order to display the current technologies available, describe the research objectives, and delineate prospective future researches. Regarding data sources, the research was conducted within three databases, PubMed Central, Web of Science, and Scopus, between January 2009 and December 2017. A total of 646 articles were found in the initial search. Accurate definition of the exclusion criteria and selection strategy allowed identification of the most relevant papers to use for the study. Finally, 56 papers were fully evaluated and included in this review. Three major clinical application areas have been portrayed, namely "Cognitive Assessment," "Treatment," and "Assistance." These have been combined with three main technological solutions, specifically "Sensors," "Personal Devices," and "Robots." Furthermore, the study of the publications time series illustrates a steadily increasing trend, characterized by the enrollment of small groups of subjects, and particularly oriented to the subjects assistance using robots companion. In conclusion, despite the new technological solutions for people with MCI have received much interest, particularly regarding robots for assistance, nowadays it still owns vast room for improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.